Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Carvajal Alejandra received 100,000 Cytomx Therapeutics, Inc. shares as an award (Form 4)
Traded Aug 3, 2026 · Filed Aug 5, 2026
On Aug 3, 2026, Carvajal Alejandra (Chief Legal Officer) received 100,000 Cytomx Therapeutics, Inc. shares as an award, leaving 100,000 shares. Filed Aug 5, 2026 (Form 4).
- Awarded
- 100,000 shares
- Holding after
- 100,000 shares
- Trading plan
- No
- Role
- Chief Legal Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 3, 2026 | Common Stock | Award | 100,000 | 100,000 | Direct |
Source
Related
- Cytomx Therapeutics, Inc.
- Carvajal Alejandra
- Cytomx Therapeutics, Inc. shareholders
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026